Acurx Stock Analysis

The recent indifference towards the small price fluctuations of Acurx Pharmaceuticals could raise concerns from insiders as the firm is trading at a share price of 0.0 on very low momentum in volume. The company executives did not add any value to Acurx Pharmaceuticals investors in September. However, most investors can still diversify their portfolios with Acurx Pharmaceuticals to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to insiders with longer-term investment horizons.
Check out Trending Equities.
The Acurx Pharmaceuticals stock analysis report makes it easy to digest most publicly released information about Acurx Pharmaceuticals and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Acurx Stock analysis module also helps to analyze the Acurx Pharmaceuticals price relationship with some important fundamental indicators such as market cap and management efficiency.

Acurx Stock Analysis Notes

About 23.0% of the company shares are held by company insiders. The book value of Acurx Pharmaceuticals was presently reported as 1.41. The company recorded a loss per share of 1.48. Acurx Pharmaceuticals had not issued any dividends in recent years. Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. For more info on Acurx Pharmaceuticals please contact the company at 917-533-1469 or go to

Acurx Pharmaceuticals Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Acurx Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Acurx Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Acurx Pharmaceuticals is not yet fully synchronised with the market data
Acurx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (13.94 M).
Acurx Pharmaceuticals currently holds about 11.08 M in cash with (6.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08.
Roughly 23.0% of the company shares are held by company insiders

Acurx Pharmaceuticals Upcoming and Recent Events

Earnings reports are used by Acurx Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Acurx Pharmaceuticals previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report11th of February 2022
Next Fiscal Quarter End31st of December 2021

Acurx Pharmaceuticals SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Acurx Pharmaceuticals prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Acurx Pharmaceuticals investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Acurx Pharmaceuticals specific information freely available to individual and institutional investors to make a timely investment decision.
15th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
25th of July 2022
Financial Statements and Exhibits. Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics. Unregistered Sales of Equity Securities. Results of Operations and Financial Condition. Entry into a Material Definitive Agreement
7th of June 2022
Submission of Matters to a Vote of Security Holders
11th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
17th of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition

Acurx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Acurx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acurx Pharmaceuticals backward and forwards among themselves. Acurx Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Acurx Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Draper Asset Management LlcCommon Shares266 KM
Blackrock IncCommon Shares16 K61 K
Castle Wealth Management LlcCommon Shares13 K49 K
Geode Capital Management LlcCommon Shares11.5 K43 K
Advisor Group Holdings IncCommon Shares11 K42 K
Tocqueville Asset Management LpCommon Shares10.1 K38 K
Patriot Financial Group Insurance Agency LlcCommon Shares9.8 K37 K
Note, although Acurx Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Acurx Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 32.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acurx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Acurx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (122.43) % which means that it has lost $122.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (211.9) %, meaning that it created substantial loss on money invested by shareholders. Acurx Pharmaceuticals management efficiency ratios could be used to measure how well acurx pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Acurx Pharmaceuticals Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acurx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acurx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acurx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Acurx Pharmaceuticals Predictive Daily Indicators

Acurx Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Acurx Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Acurx Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Acurx Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acurx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Acurx Pharmaceuticals. By using and applying Acurx Stock analysis, traders can create a robust methodology for identifying Acurx entry and exit points for their positions.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Acurx Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Fundamentals Comparison Now


Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module
Please continue to Trending Equities. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Tools for Acurx Stock

When running Acurx Pharmaceuticals price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account